NCT06126406 Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes(CAR-T) for CEA Positive Advanced Malignant Solid Tumors Status RECRUITING Phase PHASE1
NCT06107920 Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy Status RECRUITING Phase PHASE3
NCT06081647 The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy Procedure Status RECRUITING Phase NA
NCT06065592 Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms Status RECRUITING Phase PHASE1
NCT06053996 Hepatopulmonary Radio-sterilization With Immunotherapy Status NOT_YET_RECRUITING Phase NA
NCT06051695 A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression Status RECRUITING Phase PHASE1/PHASE2
NCT06050447 Factors Affecting the Results of Treatment of Patients With Colorectal Cancer Status RECRUITING Phase N/A
NCT06014372 Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer Status RECRUITING Phase PHASE2
NCT06010862 Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Status RECRUITING Phase PHASE1
NCT06009484 VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program Status COMPLETED Phase N/A
NCT06006390 CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05973266 The Effect of Mobile Application-Based Bowel Preparation Training on the Patient's Education Whom Colonoscopy is Planned Status UNKNOWN Phase NA
NCT05961709 The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05943951 Italian Study on the Right Hemicolectomy: How the Lymphadenectomy is Performed Status COMPLETED Phase N/A
NCT05900648 Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME) Status WITHDRAWN Phase PHASE2
NCT05875402 XKDCT080 in GCC-positive Recurrent or Refractory Solid Tumors With Single Center, Single Arm, and Dose Escalation Status UNKNOWN Phase NA
NCT05872334 The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery Status COMPLETED Phase NA